Back to top
more

Lilly Eli & Co: (LLY)

(Market Close from NYSE)

 Add to portfolio

Save at Trade

$79.80 USD

79.80
4,270,580

-2.55 (-3.10%)

Updated Sep 1, 2015 04:03 PM ET

Volume: 4,270,580

Open: $80.25

Prior Close: $82.35

Zacks Rank : 2-Buy [?]   2      

Style Scores [?] : Growth: C | Value: C | Momentum: C

The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. It allows the investor to better focus on the stocks that are the best fit for his or her personal investment style.

We produce five unique ratings, including the Zacks Style Score, which combines the individual style scores into 1 rating:

Zacks Style Score A
Growth Score A
Value Score A
Momentum Score A
Income Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a score of an A or a B in your personal trading style.

Zacks Scorecard Education - Learn more about the Zacks Scorecard

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The three scores are based on the trading styles of Growth, Value, and Momentum.

Growth Score A
Value Score A
Momentum Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Company Summary

Eli Lilly and Company discovers, develops, manufactures, and sells products in one significant business segment -pharmaceutical products. The company directs its research efforts primarily toward the search for products to diagnose, prevent and treat human diseases. The company also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

General Information

LILLY ELI & CO

LILLY CORPORATE CTR DROP CODE 1112

INDIANAPOLIS, IN 46285

Phone: 317-276-2000

Fax: 317-276-4878

Web: http://www.lilly.com

Email: johnson_philip_l@lilly.com

Industry LARGE CAP PHARMA
Sector Medical
Fiscal Year End December
Last Reported Quarter 6/30/2015
Next EPS Date 10/22/2015

EPS Information

Current Quarter EPS Consensus Estimate 0.75
Current Year EPS Consensus Estimate 3.27
Estimated Long-Term EPS Growth Rate 13.30
Next EPS Report Date 10/22/2015

Price and Volume Information

Zacks Rank
Yesterday's Close 82.35
52 Week High 90.18
52 Week Low 60.58
Beta 0.26
20 Day Moving Average 4,621,580.50
Target Price Consensus 90.09

LLY

% Price Change
4 Week -5.06
12 Week -3.59
YTD 19.37
% Price Change Relative to S&P 500
4 Week 3.85
12 Week 4.79
YTD 24.83
Share Information
Shares Outstanding (millions) 1,108.54
Market Capitalization (millions) 88,461.58
Short Ratio 2.49
Last Split Date 10/16/1997
Dividend Information
Dividend Yield 2.51%
Annual Dividend $2.00
Payout Ratio 0.63
Change in Payout Ratio 0.10
Last Dividend Payout / Amount 8/12/2015 / $0.50

Fundamental Ratios

P/E
P/E (F1) 24.38
Trailing 12 Months 25.09
PEG Ratio 1.83
EPS Growth
vs. Previous Year 32.35%
vs. Previous Quarter 3.45%
   
Sales Growth
vs. Previous Year 0.87%
vs. Previous Quarter 7.19%
   
Price Ratios
Price/Book 6.03
Price/Cash Flow 20.35
Price / Sales 4.51
ROE
6/30/15 21.57
3/31/15 19.16
12/31/14 17.22
ROA
6/30/15 9.43
3/31/15 8.87
12/31/14 8.44
Current Ratio
6/30/15 1.50
3/31/15 1.41
12/31/14 1.09
Quick Ratio
6/30/15 1.10
3/31/15 1.05
12/31/14 0.84
Operating Margin
6/30/15 17.24
3/31/15 16.15
12/31/14 15.23
Net Margin
6/30/15 10.50
3/31/15 11.20
12/31/14 12.19
Pre-Tax Margin
6/30/15 12.57
3/31/15 13.93
12/31/14 15.30
Book Value
6/30/15 13.24
3/31/15 13.45
12/31/14 13.82
Inventory Turnover
6/30/15 1.66
3/31/15 1.67
12/31/14 1.68
Debt-to-Equity
6/30/15 0.54
3/31/15 0.50
12/31/14 0.35
Debt to Capital
6/30/15 35.20
3/31/15 33.16
12/31/14 25.86